Agglutination 
Inhibition Study on Pan-phytagglutinin Caragana chamlagu Lam

Keimyung Medical Journal 1983;2(1):39-44.

Agglutination Inhibition Study on Pan-phytagglutinin Caragana chamlagu Lam

범식물응집소 Caragana chamlagu Lam의 응집조지에 관한 연구

김정주; 문국진

Abstract

Since blood groups and histocompatibility were discovered; they have been applied in several fields of medicine which include transfusion; organ transplantation; identification of paternity; diagnosis of certain specific diseases and study of ethnology. In this study; the author demonstrated that the panhemagglutination activity of C. Chamlagu extract was inhibited by certain sera; while in others it was not. Therefore; the author designated the former as CCI (Caragana Chamlagu Inhibitor) and the latter as CCN (Caragana Chamlagu Non-inhibitor). Samples taken from 873 cases were composed of 250 blood donors; 244 traumatic cases; 92 puer-perants; and 287 cases of paternity identification. The author also analyzed the frequencies of the CCI and CCN in comparison with blood groups and types; i.e. ABO; Rh subtypes (CDEce); MNSs and secretor types. The results were as follows: 1. Normal distributions of CCI and CCN were 71.33% and 28.67% respectively. 2. There were statistically no significant differences between normal distributions and each distribution of the blood groups and types.